Literature DB >> 33424804

Imaging Mass Cytometric Analysis of Postmortem Tissues Reveals Dysregulated Immune Cell and Cytokine Responses in Multiple Organs of COVID-19 Patients.

Chong Wang1,2, Jiqian Xu3, Shaoyuan Wang4, Shangwen Pan3, Jiancheng Zhang3, Yang Han2,5,6, Muhan Huang2,5, Di Wu2,5, Qingyu Yang6, Xiaobo Yang3, Yang Yang4, Ting Shu5,6, Xiaojing Zou3, Ruiting Li3, Yufeng Luo4, Runqing Yao4, Yaxin Wang3, Yang Qiu2,5, Yu Wang7, Ding-Yu Zhang6, Qun Yao6, Yongpan Yan4, Xi Zhou2,5,6, You Shang3,6,8.   

Abstract

SARS-coronavirus-2-induced immune dysregulation and inflammatory responses are involved in the pathogenesis of coronavirus disease-2019 (COVID-19). However, very little is known about immune cell and cytokine alterations in specific organs of COVID-19 patients. Here, we evaluated immune cells and cytokines in postmortem tissues, i.e., lungs, intestine, liver, kidneys, and spleen of three patients with COVID-19. Imaging mass cytometry revealed monocyte, macrophage, and dendritic cell (DC) infiltration in the lung, intestine, kidney, and liver tissues. Moreover, in patients with COVID-19, natural killer T cells infiltrated the liver, lungs, and intestine, whereas B cells infiltrated the kidneys, lungs, and intestine. CD11b+ macrophages and CD11c+ DCs also infiltrated the lungs and intestine, a phenomenon that was accompanied by overproduction of the immunosuppressive cytokine interleukin (IL)-10. However, CD11b+ macrophages and CD11c+ DCs in the lungs or intestine of COVID-19 patients did not express human leukocyte antigen DR isotype. In contrast, tumor necrosis factor (TNF)-α expression was higher in the lungs, intestine, liver, and kidneys, but not in the spleen, of all COVID-19 patients (compared to levels in controls). Collectively, these findings suggested that IL-10 and TNF-α as immunosuppressive and pro-inflammatory agents, respectively,-might be prognostic and could serve as therapeutic targets for COVID-19.
Copyright © 2020 Wang, Xu, Wang, Pan, Zhang, Han, Huang, Wu, Yang, Yang, Yang, Shu, Zou, Li, Luo, Yao, Wang, Qiu, Wang, Zhang, Yao, Yan, Zhou and Shang.

Entities:  

Keywords:  COVID-19; imaging mass cytometry (IMC); immune dysregulation; inflammatory response; organ specific response

Year:  2020        PMID: 33424804      PMCID: PMC7785801          DOI: 10.3389/fmicb.2020.600989

Source DB:  PubMed          Journal:  Front Microbiol        ISSN: 1664-302X            Impact factor:   5.640


  13 in total

Review 1.  SARS CoV-2-Induced Viral Sepsis: The Role of Gut Barrier Dysfunction.

Authors:  Stelios F Assimakopoulos; Gerasimos Eleftheriotis; Maria Lagadinou; Vassilios Karamouzos; Periklis Dousdampanis; Georgios Siakallis; Markos Marangos
Journal:  Microorganisms       Date:  2022-05-19

2.  Human small intestinal infection by SARS-CoV-2 is characterized by a mucosal infiltration with activated CD8+ T cells.

Authors:  Anja A Kühl; Britta Siegmund; Malte Lehmann; Kristina Allers; Claudia Heldt; Jenny Meinhardt; Franziska Schmidt; Yasmina Rodriguez-Sillke; Désirée Kunkel; Michael Schumann; Chotima Böttcher; Christiane Stahl-Hennig; Sefer Elezkurtaj; Christian Bojarski; Helena Radbruch; Victor M Corman; Thomas Schneider; Christoph Loddenkemper; Verena Moos; Carl Weidinger
Journal:  Mucosal Immunol       Date:  2021-08-21       Impact factor: 7.313

Review 3.  Using Imaging Mass Cytometry to Define Cell Identities and Interactions in Human Tissues.

Authors:  Vijayakumar R Kakade; Marlene Weiss; Lloyd G Cantley
Journal:  Front Physiol       Date:  2021-12-22       Impact factor: 4.566

4.  Disrupted Peyer's Patch Microanatomy in COVID-19 Including Germinal Centre Atrophy Independent of Local Virus.

Authors:  Silvia C Trevelin; Suzanne Pickering; Katrina Todd; Cynthia Bishop; Michael Pitcher; Jose Garrido Mesa; Lucia Montorsi; Filomena Spada; Nedyalko Petrov; Anna Green; Manu Shankar-Hari; Stuart J D Neil; Jo Spencer
Journal:  Front Immunol       Date:  2022-02-17       Impact factor: 7.561

Review 5.  New Discovery of Myeloid-Derived Suppressor Cell's Tale on Viral Infection and COVID-19.

Authors:  Soo-Jeung Park; Da-Eun Nam; Hae Chang Seong; Young S Hahn
Journal:  Front Immunol       Date:  2022-02-03       Impact factor: 7.561

Review 6.  The role of natural killer cells in liver inflammation.

Authors:  A J Highton; I S Schuster; M A Degli-Esposti; M Altfeld
Journal:  Semin Immunopathol       Date:  2021-07-07       Impact factor: 9.623

7.  A cohort autopsy study defines COVID-19 systemic pathogenesis.

Authors:  Xiao-Hong Yao; Tao Luo; Yu Shi; Zhi-Cheng He; Rui Tang; Pei-Pei Zhang; Jun Cai; Xiang-Dong Zhou; Dong-Po Jiang; Xiao-Chun Fei; Xue-Quan Huang; Lei Zhao; Heng Zhang; Hai-Bo Wu; Yong Ren; Zhen-Hua Liu; Hua-Rong Zhang; Cong Chen; Wen-Juan Fu; Heng Li; Xin-Yi Xia; Rong Chen; Yan Wang; Xin-Dong Liu; Chang-Lin Yin; Ze-Xuan Yan; Juan Wang; Rui Jing; Tai-Sheng Li; Wei-Qin Li; Chao-Fu Wang; Yan-Qing Ding; Qing Mao; Ding-Yu Zhang; Shu-Yang Zhang; Yi-Fang Ping; Xiu-Wu Bian
Journal:  Cell Res       Date:  2021-06-16       Impact factor: 46.297

Review 8.  A bird's eye view on the role of dendritic cells in SARS-CoV-2 infection: Perspectives for immune-based vaccines.

Authors:  Domenico Galati; Serena Zanotta; Ludovica Capitelli; Marialuisa Bocchino
Journal:  Allergy       Date:  2021-07-24       Impact factor: 14.710

9.  Hyperion Image Analysis Depicts a Preliminary Landscape of Tumor Immune Microenvironment in OSCC with Lymph Node Metastasis.

Authors:  Shang Xie; Xin-Yuan Zhang; Xiao-Feng Shan; Vicky Yau; Jian-Yun Zhang; Wei Wang; Yong-Pan Yan; Zhi-Gang Cai
Journal:  J Immunol Res       Date:  2021-06-21       Impact factor: 4.818

10.  Disrupted Resolution Mechanisms Favor Altered Phagocyte Responses in COVID-19.

Authors:  Issa Beegun; Charlotte Camille Jouvene; Duco Steven Koenis; Gabriel Amador Aguirre; Patricia Regina Souza; Maria Gonzalez-Nunez; Lucy Ly; Kimberly Pistorius; Hemant M Kocher; William Ricketts; Gavin Thomas; Mauro Perretti; Ghassan Alusi; Paul Pfeffer; Jesmond Dalli
Journal:  Circ Res       Date:  2021-07-09       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.